2021
DOI: 10.1016/j.bja.2021.08.022
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic potential of long-acting opioids and opioid antagonists for SARS-CoV-2 infection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“… 14 Moreover, there are recent data suggesting an interaction between opioids, COVID infection and outcome. 111 , 112 , 113 , 114 The precise target site for immunomodulation is controversial with three areas of interest; none fully explains immune modulation. These are (i) the immune cell itself, (ii) modulation of the hypothalamic–pituitary–adrenal (HPA) axis and (iii) central actions.…”
Section: Opioids—opioid Receptors and Immunomodulationmentioning
confidence: 99%
“… 14 Moreover, there are recent data suggesting an interaction between opioids, COVID infection and outcome. 111 , 112 , 113 , 114 The precise target site for immunomodulation is controversial with three areas of interest; none fully explains immune modulation. These are (i) the immune cell itself, (ii) modulation of the hypothalamic–pituitary–adrenal (HPA) axis and (iii) central actions.…”
Section: Opioids—opioid Receptors and Immunomodulationmentioning
confidence: 99%